thiazoles has been researched along with Diseases, Metabolic in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnold, M; Baillie, RA; Blach, C; Casanova, R; Chang, R; Dallmann, G; Demirkan, A; Doraiswamy, PM; Han, X; Hankemeier, T; Harms, AC; Henrion, MYR; Jack, JR; John-Williams, LS; Kaddurah-Daouk, R; Kastenmüller, G; Kim, S; Klavins, K; Koal, T; Legido-Quigley, C; Louie, G; Lucas, JE; MahmoudianDehkordi, S; Massaro, T; Moseley, MA; Motsinger-Reif, A; Nho, K; Risacher, SL; Rotroff, DM; Saykin, AJ; Shaw, LM; Shen, L; Suhre, K; Tenenbaum, JD; Thambisetty, M; Thompson, JW; Toledo, JB; Trojanowski, JQ; van der Lee, SJ; van Duijn, CM; Varma, S; Weiner, MW; Zhu, H; Zhu, K | 1 |
| Dai, G; Zhang, Y | 1 |
| Alexopoulos, P; Auer, F; Diehl-Schmid, J; Drzezga, A; Förster, S; Förstl, H; Grimmer, T; Kurz, A; Ortner, M; Perneczky, R; Sorg, C; Yousefi, BH | 1 |
| Alonso-Martín, C; Arias-Loste, MT; Crespo, J; Crespo-Facorro, B; Fábrega, E; Martínez-García, O; Morlán-Coarasa, MJ; Ortiz-García de la Foz, V; Romero-Gómez, M | 1 |
| Calabrese, JR; Ice, KS; Karayal, ON; Kemp, DE; Pappadopulos, E; Sachs, GS; Siu, CO; Vieta, E | 1 |
| Becker, MA; Chefo, S; Chohan, S; Jackson, RL; MacDonald, PA | 1 |
| Balbo, E; Delgado, JF; Diez, T; Martin, E; Montes, JM; Rodriguez, JL; Sopelana, P; Soto, JA; Villardaga, I | 1 |
| Currier, JS | 1 |
| Bodkin, NL; Hansen, BC; Kliewer, SA; Lambert, MH; Lewis, MC; Oliver, WR; Plunket, KD; Russell, CS; Shenk, JL; Snaith, MR; Sternbach, DD; Sznaidman, ML; Willson, TM; Winegar, DA; Xu, HE | 1 |
| Kanai, H; Kurabayashi, M; Kuro-o, M; Nabeshima, Y; Nagai, R; Nakamura, T; Saito, Y; Sumino, H; Takeda, S; Yamagishi, T | 1 |
| Abbasi, F; Chu, JW; Cooke, JP; Lamendola, C; McLaughlin, TL; Reaven, GM; Stühlinger, MC; Tsao, PS | 1 |
4 trial(s) available for thiazoles and Diseases, Metabolic
| Article | Year |
|---|---|
Efficacy and metabolic influence of paliperidone ER, aripiprazole and ziprasidone to patients with first-episode schizophrenia through 52 weeks follow-up in China.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Body Mass Index; China; Delayed-Action Preparations; Diagnostic and Statistical Manual of Mental Disorders; Female; Follow-Up Studies; Humans; Hyperglycemia; Hyperlipidemias; Isoxazoles; Male; Metabolic Diseases; Paliperidone Palmitate; Piperazines; Psychiatric Status Rating Scales; Pyrimidines; Quinolones; Schizophrenia; Thiazoles; Weight Gain; Young Adult | 2012 |
Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year prospective randomized interventional study.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Female; Humans; Incidence; Male; Metabolic Diseases; Middle Aged; Non-alcoholic Fatty Liver Disease; Piperazines; Prospective Studies; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Young Adult | 2016 |
Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: long-term changes in weight and metabolic profiles.
Topics: Adjuvants, Immunologic; Antipsychotic Agents; Bipolar Disorder; Body Weight; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lithium Chloride; Longitudinal Studies; Male; Metabolic Diseases; Metabolome; Piperazines; Psychiatric Status Rating Scales; Thiazoles; Valproic Acid | 2012 |
Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Cardiovascular Diseases; Comorbidity; Febuxostat; Female; Gout; Gout Suppressants; Humans; Hyperuricemia; Illinois; Male; Metabolic Diseases; Middle Aged; Obesity; Retrospective Studies; Sex Factors; Thiazoles; Treatment Outcome; Uric Acid; Young Adult | 2012 |
7 other study(ies) available for thiazoles and Diseases, Metabolic
| Article | Year |
|---|---|
Metabolic network failures in Alzheimer's disease: A biochemical road map.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Amino Acids; Amyloid beta-Peptides; Aniline Compounds; Cognitive Dysfunction; Cohort Studies; Cross-Sectional Studies; Fasting; Female; Humans; Male; Metabolic Diseases; Metabolic Networks and Pathways; Metabolomics; Peptide Fragments; Phosphatidylcholines; Sphingomyelins; tau Proteins; Thiazoles | 2017 |
Small vessel disease, but neither amyloid load nor metabolic deficit, is dependent on age at onset in Alzheimer's disease.
Topics: Age of Onset; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Aniline Compounds; Apolipoproteins E; Benzothiazoles; Brain; Female; Fluorodeoxyglucose F18; Humans; Male; Metabolic Diseases; Middle Aged; Radionuclide Imaging; Thiazoles; Vascular Diseases | 2015 |
Improvement in antipsychotic-related metabolic disturbances in patients with schizophrenia switched to ziprasidone.
Topics: Adult; Antipsychotic Agents; Blood Glucose; Body Weight; Cholesterol; Female; Humans; Male; Metabolic Diseases; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Retrospective Studies; Schizophrenia; Severity of Illness Index; Statistics, Nonparametric; Thiazoles; Time Factors | 2007 |
How to manage metabolic complications of HIV therapy: what to do while we wait for answers.
Topics: Anabolic Agents; Anti-HIV Agents; Anticholesteremic Agents; Atorvastatin; Exercise Therapy; Gemfibrozil; Growth Hormone; Guidelines as Topic; Heptanoic Acids; HIV Infections; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Lipodystrophy; Metabolic Diseases; Metformin; Nucleosides; Protease Inhibitors; Pyrroles; Reverse Transcriptase Inhibitors; Risk Factors; Thiazoles; Thiazolidinediones | 2000 |
A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport.
Topics: Animals; Apolipoprotein A-I; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Biological Transport; Blood Glucose; Cell Line; Cholesterol; Cholesterol, HDL; Drug Design; Fasting; Fibroblasts; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Intestinal Mucosa; Intestines; Macaca mulatta; Macrophages; Male; Metabolic Diseases; Obesity; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Substrate Specificity; Thiazoles; Transcription Factors; Triglycerides | 2001 |
Troglitazone improves endothelial function and augments renal klotho mRNA expression in Otsuka Long-Evans Tokushima Fatty (OLETF) rats with multiple atherogenic risk factors.
Topics: Animals; Arteriosclerosis; Chromans; Endothelium, Vascular; Glucuronidase; Hypertension; Kidney; Klotho Proteins; Male; Membrane Proteins; Metabolic Diseases; Obesity; Rats; Rats, Inbred OLETF; Risk Factors; RNA, Messenger; Thiazoles; Thiazolidinediones; Troglitazone; Vasodilator Agents | 2001 |
Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor.
Topics: Adult; Aged; Arginine; Cardiovascular Diseases; Cross-Sectional Studies; Enzyme Inhibitors; Female; Humans; Hypertension; Hypoglycemic Agents; Lipoproteins; Male; Metabolic Diseases; Metabolic Syndrome; Middle Aged; Nitric Oxide Synthase; Regression Analysis; Risk Factors; Rosiglitazone; Thiazoles; Thiazolidinediones; Vasodilator Agents | 2002 |